FDA Grants Clearance For Big Health’s DaylightRx Anxiety Treatment  

The FDA granted clearance for digital therapeutic DaylightRx from Big Health. DaylightRx is a prescription device delivering cognitive behavioral therapy, intended to treat generalized anxiety disorder (GAD) as an adjunct to usual care in adults aged 22 years and older.;

DaylightRx teaches consumers evidence-based techniques to change the thoughts and behaviors that maintain chronic worry and anxiety. It includes interactive lessons on applied relaxation, stimulus control, cognitive restructuring, and exposure to reduce intensity of worry. DaylightRx includes guided practice exercises designed to support users in integrating these techniques into their daily lives.;

DaylightRx was developed based on . . .